ULTOMIRIS® (ravulizumab) Receives Approval in Japan for Atypical Hemolytic Uremic Syndrome (aHUS) in Adults and Children
– ULTOMIRIS is the first and only long-acting C5 inhibitor for aHUS, reducing the treatment…
– ULTOMIRIS is the first and only long-acting C5 inhibitor for aHUS, reducing the treatment…
ENHERTU is the first and only HER2 directed medicine to demonstrate significant improvement in overall…
TAIPEI, Taiwan--(BUSINESS WIRE)--#ai--The 2020 Taiwan Innotech Expo's (TIE’s) Innovation Pilot Pavilion, organized by the Industrial…
SAB to provide strategic guidance for the global development of Clover’s COVID-19 vaccine program Comprised…
DUBLIN--(BUSINESS WIRE)--The "Dairy Products China News" newsletter has been added to ResearchAndMarkets.com's offering. Dairy Products…
BEIJING--(BUSINESS WIRE)--#ai--Artificial Intelligence Defense Platform, a technology start-up creating AI technology for a safer, more…
DUBLIN--(BUSINESS WIRE)--The "India Bathing Soap Market Overview, 2020-2025" report has been added to ResearchAndMarkets.com's offering.…
SHANGHAI--(BUSINESS WIRE)--Since early 2020 when the COVID-19 pandemic broke out worldwide, the luxury market has…
DUBLIN--(BUSINESS WIRE)--The "Australia Green Mining Market By Mining Type (Surface and Underground), By Technology (Power…
DUBLIN--(BUSINESS WIRE)--The "Myanmar Air Conditioner (AC) Volume Analysis, by Types [Room AC (Window-Type, Split-Type(single)) &…